Pharmacometrics analyses and modelling of concentration‐corrected QT interval and concentration‐creatine kinase MB in healthy adults and treatment‐naïve people with HIV‐1 on ainuovirine monotherapy, and combined with lamivudine and tenofovir DF: The pooled analyses of early clinical pharmacology studies

Ähnliche Einträge

• Safety, pharmacokinetics and antiviral activity of ainuovirine as 10‐day monotherapy in treatment‐naïve adults with HIV‐1
  Veröffentlicht: (2024)
• Effect of fluconazole on the pharmacokinetics of ainuovirine in healthy adult subjects
  Veröffentlicht: (2024)
• Physicochemical stability of DELSTRIGO®: A combination of three active substances (tenofovir disoproxi fumarate [TDF], lamivudine [3TC] doravirine [DOR]) in the management of occupational in the management of HIV post‐exposure prophylaxis (PEP)
  von: E. Hindes, et al.
  Veröffentlicht: (2025)
• Lamivudine and tenofovir pharmacokinetic variability in people with HIV in Papua New Guinea
  von: Natália Bordin Andriguetti, et al.
  Veröffentlicht: (2025)
• No observed bidirectional effect between tenofovir diphosphate concentrations and gender‐affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre‐exposure prophylaxis
  von: Nimish Patel, et al.
  Veröffentlicht: (2024)